Corcept Therapeutics
(CORT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | 12-2003 | 12-2002 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 5,930 | 10,073 | N/A |
| Marketable Securities | 31,471 | 1,504 | N/A |
| TOTAL | $38,239 | $11,743 | $N/A |
| Non-Current Assets | |||
| PPE Net | N/A | 1 | N/A |
| Investments And Advances | 9,486 | 0 | 0 |
| Other Non-Current Assets | 47 | 38 | 0 |
| TOTAL | $9,533 | $38 | $N/A |
| Total Assets | $47,772 | $11,781 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 550 | 322 | 0 |
| Accrued Expenses | 1,001 | 334 | N/A |
| Other current liabilities | 273 | N/A | N/A |
| TOTAL | $1,824 | $1,014 | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 524 | 0 |
| TOTAL | $N/A | $524 | $N/A |
| Total Liabilities | $1,824 | $1,538 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 22,694 | N/A | N/A |
| Common Shares | 23 | 9 | N/A |
| Retained earnings | -53,472 | -37,937 | N/A |
| Other shareholders' equity | -1,964 | 39,190 | 0 |
| TOTAL | $45,948 | $10,243 | $N/A |
| Total Liabilities And Equity | $47,772 | $11,781 | $0 |